Nirav Shah
Samphire Group, Inc. · Medical College of Wisconsin · Medical College of Wisconsin Clinical Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nirav Shah as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:56 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07679074 · CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of LifeSamphire Group, Inc. · recruiting · Premenstrual Syndrome, Premenstrual Dysphoric Disorder, Dysmenorrhea · principal investigator
- Ph1NCT07335328 · Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell MalignanciesMedical College of Wisconsin · not yet recruiting · B-cell Non Hodgkin Lymphoma · principal investigator
- N/ANCT06974773 · Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare UpsSamphire Group, Inc. · recruiting · Endometriosis · principal investigator
- Ph2NCT06594939 · Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell LymphomaMedical College of Wisconsin · recruiting · Diffuse Large B Cell Lymphoma (DLBCL) · study chair
- Ph1NCT05990465 · LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell MalignanciesMedical College of Wisconsin · recruiting · Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma · principal investigator
- Ph1NCT05094206 · CAR20.19.22 T-cells in Relapsed, Refractory B-cell MalignanciesMedical College of Wisconsin · terminated · B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia · principal investigator
- Ph1/Ph2NCT04186520 · CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell MalignanciesMedical College of Wisconsin · recruiting · Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL) · principal investigator
- Ph2NCT03943901 · Split-Dose R-CHOP for Older Adults With DLBCLUniversity of Wisconsin, Madison · active not recruiting · Diffuse Large B Cell Lymphoma, DLBCL, Cancer · study chair
- Ph1NCT03588936 · Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic TransplantMedical College of Wisconsin · terminated · Acute Leukemia, Chronic Leukemia, Lymphoma · principal investigator
- N/ANCT03375619 · Long-term Follow-up Study of Patients Receiving CAR-T CellsMedical College of Wisconsin · recruiting · Chronic Lymphocytic Leukemia, Lymphomas Non-Hodgkin's B-Cell, Lymphoma, Small Lymphocytic · principal investigator
- Ph1NCT03019055 · Study of CAR-20/19-T Cells in Patients With Relapsed Refractory B CellMedical College of Wisconsin · completed · Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Chronic Lymphocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- BMT Core- Medical College of WisconsinUG1HL138641 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · fiscal years 2022 to 2026 · $234,000 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:56 UTC. The ranking covers the 200 most relevant of 498 PubMed records, and a shared surname and initials can bring in a namesake. All 498 on PubMed
- 2,446 citationsRCR 71.3
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.N Engl J Med · 20212,208 citationsRCR 120.1
- Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.N Engl J Med · 20061,367 citationsRCR 27.7
- Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.N Engl J Med · 20101,247 citationsRCR 28.0
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.Nat Med · 20181,142 citationsRCR 36.1
- 913 citationsRCR 25.5
- A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.N Engl J Med · 2013903 citationsRCR 24.7
- Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.J Clin Oncol · 2016778 citationsRCR 26.0
- Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer.N Engl J Med · 2019713 citationsRCR 26.7
- 625 citationsRCR 29.5